Recent Posts
- Pulmonary Arterial Hypertension (PAH): Types of Medicines November 19, 2024
- WHO Approves World’s First Diagnostic Test for MPox October 9, 2024
- FDA Approves Miplyffa: First-Ever Drug for Niemann-Pick Disease, Type C (NPC) September 26, 2024
- Accessing Selpercatinib (Retevmo/Retsevmo) for RET-Positive Cancers September 24, 2024
- Primary Biliary Cholangitis (PBC): Symptoms, Causes, and Treatment September 19, 2024
Categories
- Achondroplasia 1
- acute lymphocytic leukemia 12
- Adrenal Cancer 1
- adrenal gland 2
- ALL 3
- AML 4
- Atriance 3
- B cell maturation antigen 1
- Bladder Cancer 4
- blood cancer 2
- Brain Metastasis 3
- Breast Cancer 13
- Chronic Lymphocytic Leukemia 2
- CML 3
- CMV 2
- Counterfeit Drugs 1
- Crohn’s disease 3
- Cushing's Disease 1
- Cushing’s Disease 1
- DLBCL 5
- DMD 1
- Drug & Cosmetic Act 1
- Enhertu 4
- FDA approval for Colorectal cancer & small lymphocytic lymphoma Treatment 1
- FDA NEWS 12
- gene therapy 2
- Heart Health and Weight Management 1
- Hemophilia 1
- Hemophilia Treatment 1
- hereditary tyrosinemia 1
- HGBL 1
- Hodgkin Lymphoma 4
- IPN 1
- kineret 7
- leukaemia 2
- Lymphoma 1
- Lysodren 1
- manage access program 1
- Metastatic Breast Cancer 7
- metastatic colorectal cancer 4
- metastatic urothelial cancer 3
- multiple Myeloma 2
- myelodysplastic syndromes 1
- name patient import 1
- named patient program india 2
- Nelarabine 1
- News 17
- Non-small cell lung cancer medication 2
- NSCLC 2
- NSCLE 1
- Ovarian Cancer 1
- Pancreatic Cancer 1
- PLAQUE PSORIASIS 2
- PNH 2
- Polivy 1
- porphyria 1
- Primary Biliary Cholangitis PBC 1
- Psoriatic arthritis 2
- Pulmonary Arterial Hypertension PAH 1
- pyelonephritis 1
- rare diseases 1
- RETEVMO 3
- Retsevmo 1
- rheumatoid arthritis 3
- Rheumatoid Arthritis: 1
- Stomach Gastric Cancer 1
- T-cell Acute Lymphoblastic Leukaemia 3
- thyroid carcinoma 1
- Trodelvy 3
- tukysa 1
- Type 2 Diabetes 1
- weight loss medicine 1
- Wilson's Disease 1
- World Health Organization WHO 1